Johnson & Johnson's Spravato gains FDA nod to be used as a monotherapy - FiercePharma

Submitted by Anonymous (not verified) on Tue, 01/21/2025 - 20:23

Johnson & Johnson's Spravato gains FDA nod to be used as a monotherapy  FiercePharma